DCDC2 and intrahepatic cholangiocarcinoma: Moreover, the existence of DCDC2 autoantibody was examined in Fudan cohort-III, consisted of the serum from healthy donors (HD), patients with cholelithiasis (CLS), with gallbladder cancer (GBC), with ECC, or with ICC.